Martin Schoen, MD, PhD, discusses factors guiding ARPI selection in prostate cancer and how real-world evidence can help inform treatment decisions.
Martin Schoen, MD, PhD
Advertisement
Articles by Martin Schoen, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Urology Times
1
Prof Declan Murphy discusses PROTEUS pathologic response findings in prostate cancer
2
FDA updates in urology: August 2026
3
Timothy McClure, MD, on 2-year PRESERVE trial results for focal IRE
4
Zachary Feuer, MD, on building a rapid access program for prostate cancer diagnostic evaluation
5